Drug's effect on head and neck cancer markers tested before surgery
NCT ID NCT03138070
First seen Feb 01, 2026 · Last updated May 23, 2026 · Updated 10 times
Summary
This study looked at how a drug called BYL719 affects certain proteins in head and neck cancer tumors. Fifteen patients took the drug for a short time before their planned surgery. Researchers compared tumor samples taken before and after treatment to see if the drug changed specific markers. The goal was to learn more about the cancer, not to treat it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
London Health Sciences Centre, London Regional Cancer Program
London, Ontario, N6A 4L6, Canada
Conditions
Explore the condition pages connected to this study.